Advanced Solid Cancers
Oncology
3
Pipeline Programs
2
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
1
0
1
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Monoclonal Antibody
1100%
+ 2 programs with unclassified modality
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Beacon TherapeuticsMA - Cambridge
1 program1
PRL3-ZUMABPhase 2/3Monoclonal Antibody1 trial
Active Trials
Bristol Myers SquibbPRINCETON, NJ
2 programs1
1
Cdc7-inhibitorPhase 1/22 trials
RapamunePhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Beacon TherapeuticsPRL3-ZUMAB
Bristol Myers SquibbCdc7-inhibitor
Bristol Myers SquibbCdc7-inhibitor
Bristol Myers SquibbRapamune
Clinical Trials (4)
Total enrollment: 45 patients across 4 trials
Phase II/III Trial of PRL3-Zumab in Advanced Solid Tumor Patients
Start: Jan 2023Est. completion: Feb 2026
Phase 2/3Recruiting
A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors
Start: May 2009Est. completion: Aug 201011 patients
Phase 1/2Terminated
A Study of BMS-863233 in Patients With Hematologic Cancer
Start: Mar 2009Est. completion: Jan 201011 patients
Phase 1/2Terminated
A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers
Start: Feb 2006Est. completion: Jul 201023 patients
Phase 1Terminated
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
4h ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
4h ago
Office Administrator
SystImmune
4h ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
4h ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
4h ago
Working Student Active Sourcing Support (m/f/d)
Mindpeak
Hamburg
4h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 45 patients
2 companies competing in this space